India
· Delayed Price · Currency is INR Shukra Pharmaceuticals Company Description
Shukra Pharmaceuticals Limited develops, manufactures, markets, and exports various drugs and dosage forms in India and internationally.
Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antibiotics, such as penicillin and cephalosporin.
The company was formerly known as Relish Pharmaceuticals Limited and changed its name to Shukra Pharmaceuticals Limited in August 2016.
Shukra Pharmaceuticals Limited was incorporated in 1993 and is based in Ahmedabad, India.
| Country | India |
| Founded | 1993 |
| Industry | Pharmaceutical Preparations |
| Employees | 182 |
| CEO | Dakshesh Shah |
Contact Details
Address: Veer House Ahmedabad, 380054 India | |
| Phone | 91 79 4800 0430 |
| Website | shukrapharmaceuticals.com |
Stock Details
| Ticker Symbol | 524632 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dakshesh Shah | Chief Executive Officer |
| Anar Patel | Chief Financial Officer |